Atlas Trials

Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children

Clinical trial NCT05381363 · TERMINATED

Trial details

NCT number
NCT05381363
Sponsor
Children's Hospital of Fudan University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19Children
Start date
2022-01-01
Primary completion
2023-01-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.